Search results
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 6 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer that was surgically removed. With ...
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 3 days agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...
Athena Bitcoin Global Announces CFO Transition
Digital Journal· 6 days ago...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...
MedTech Outlook 2024 for Latin America Released
Digital Journal· 6 days ago...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...
Promising HPV Cancer Treatment Advances in Clinical Trial By Investing.com
Investing.com· 5 days agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has reported...
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study...
KOIN News 6 Portland· 7 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 2 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 6 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The study is evaluating ...
What’s keeping the U.S. from allowing better sunscreens?
Arizona Daily Sun· 6 days agoWhen dermatologist Adewole “Ade” Adamson sees people spritzing sunscreen as if it’s cologne at the...
UnitedCFX.com - Trusted Partner in Automated AI Trading
Digital Journal· 6 days ago...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...
